|
151 |
Is the PANSS used correctly? a systematic review
Enthalten in BMC psychiatry Bd. 11, 18.7.2011, Nr. 1, date:12.2011: 1-5
|
|
|
|
152 |
Is the serotonin hypothesis/theory of depression still relevant? Methodological reflections motivated by a recently published umbrella review
Enthalten in European archives of psychiatry and clinical neuroscience Bd. 273, 15.2.2023, Nr. 1, date:2.2023: 1-3
|
|
|
|
153 |
Mirroring everyday clinical practice in clinical trial design: a new concept to improve the external validity of randomized double-blind placebo-controlled trials in the pharmacological treatment of major depression
Enthalten in BMC medicine Bd. 10, 2.7.2012, Nr. 1, date:12.2012: 1-5
|
|
|
|
154 |
Neuropsychological impairments predict the clinical course in schizophrenia
Enthalten in European archives of psychiatry and clinical neuroscience Bd. 258, 5.11.2008, Nr. 5, date:11.2008: 28-34
|
|
|
|
155 |
Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders
Enthalten in European archives of psychiatry and clinical neuroscience Bd. 257, 10.10.2006, Nr. 1, date:2.2007: 47-53
|
|
|
|
156 |
Stability of remission rates in a 3-year follow-up of naturalistic treated depressed inpatients
Enthalten in BMC psychiatry Bd. 16, 20.5.2016, Nr. 1, date:12.2016: 1-10
|
|
|
|
157 |
The European Post-marketing Observational Sertindole Study: an investigation of the safety of antipsychotic drug treatment
Enthalten in European archives of psychiatry and clinical neuroscience Bd. 260, 20.5.2009, Nr. 1, date:2.2010: 59-68
|
|
|
|
158 |
Three-Year long-term outcome of 458 naturalistically treated inpatients with major depressive episode: severe relapse rates and risk factors
Enthalten in European archives of psychiatry and clinical neuroscience Bd. 264, 4.3.2014, Nr. 7, date:10.2014: 567-575
|
|
Administration
